Your position:
m.limatoxi.com
>>
EN
>>
EN
>>
Formulation
>>
Eli Lilly Tirzepatides Phase III trial in obese or overweight adult patients in China was successful
>> article
Eli Lilly Tirzepatides Phase III trial in obese or overweight adult patients in China was successful
Editor:xuezhe Clicks:
0
Date:2023-2-10 15:21:52
Keyword:
Lilly
Healthoo Information:
Eli Lilly Tirzepatides Phase III trial in obese or overweight adult patients in China was successful
UserLogin
UserName：
Password：
The non-formal user may read the summary, the formal user can read the whole article。
please at once register the user of Heatlhoo.com
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName
Contact:
Title:
Mr.
Ms.
Password
Repeat password:
Mobile
Email
Verification code:
Company Name
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
Lilly gave up the overseas rights interests of Cindilimab, Cinda PD-1 ...
Lilly wins FDA expedited approval for Retevmo
Eli Lilly Sale of Antibiotics Brands to Eddingpharm
Eli Lilly sets up innovation center in Dalian
Eli Lilly opened a drug research center&...
Lilly intends to form commercial partnerships...
Eli Lilly plans to introduce over 10&nbs...
Competition pattern of Duloxetine formula
Eli Lilly to continue venture investment ...
Hutchison formed collaboration with Lilly
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
map
